The impact of different course of insulin treatment on beta-cell function in newly diagnosed type 2 Diabetes after short-term intensive insulin therapy
Phase of Trial: Phase IV
Latest Information Update: 26 Jul 2013
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 21 May 2012 trial phase changed from II to IV as reported by Chinese Clinical Trial Register.
- 21 May 2012 Planned end date 31 Dec 2013 added as reported by Chinese Clinical Trial Register.
- 25 Nov 2011 New trial record